Section 11.71.180. Schedule VA.

   (a) A substance shall be placed in schedule VA if it is found under AS 11.71.120(c) to have a degree of danger or probable danger to a person or the public which is less than substances listed in schedule IVA, but higher than substances listed in schedule VIA.
   (b) Schedule VA includes any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or their salts, calculated as the free anhydrous base or alkaloid, in limited quantities as specified in (1) - (6) of this subsection, which includes one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by schedule IA substances alone:
        (1) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
        (2) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
        (3) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
        (4) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;
        (5) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
        (6) not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.
   (c)   [Repealed, Sec. 1 ch 66 SLA 1987]. 
   (d) Schedule VA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the narcotic drug buprenorphine and its salts.
   (e) Schedule VA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
        (1) propylhexedrine, except when contained in a Benzedrex inhaler;
        (2) pyrovalerone.
   (f) Schedule VA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts, esters, isomers, and salts of esters and isomers if those salts, esters, or isomers promote muscle growth, whenever the existence of these salts, esters, and isomers is possible within the specific chemical designation: anabolic steroids. In this subsection, "anabolic steroids" means any drug or hormonal substance that is chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) and that promotes muscle growth; "anabolic steroids" does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the United States Secretary of Health and Human Services for that administration, unless a person prescribes, dispenses, or distributes that type of anabolic steroid for human use; "anabolic steroids" includes the following:
        (1) boldenone;
        (2) chlorotestosterone (4-chlorotestosterone);
        (3) clostebol;
        (4) dehydrochlormethyltestosterone;
        (5) dihydrotestosterone (4-dihydrotestosterone);
        (6) drostanolone;
        (7) ethylestrenol;
        (8) fluoxymesterone;
        (9) formebulone (formebolone);
        (10) mesterolone;
        (11) methandienone;
        (12) methandranone;
        (13) methandriol;
        (14) methandrostenolone;
        (15) methenolone;
        (16) methyltestosterone;
        (17) mibolerone;
        (18) nandrolone;
        (19) norethandrolone;
        (20) oxandrolone;
        (21) oxymesterone;
        (22) oxymetholone;
        (23) stanolone;
        (24) stanozolol;
        (25) testolactone;
        (26) testosterone;
        (27) trenbolone.

Authorities

11.71.900

Notes

References

AS 11.71.900 Definitions.

History

(Sec. 2 ch 45 SLA 1982; am Sec. 1 ch 66 SLA 1987; am Sec. 10 ch 76 SLA 1990; am Sec. 11 ch 53 SLA 2006)